iPSC Manufacturing Starts with the Source
For iPSC developers, scalable manufacturing begins long before the bioreactor. Pluristyx leaders explain why starting material, process discipline, automation, and shared data will help therapies reach patients reliably and affordably. The post iPSC Manufacturing Starts with the Source appeared first on GEN - Genetic Engineering and Biotechnology News .
We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.
